Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Learn Details Of Insulin Glargine Market By Manufacturers, Regions, Type And Application, Forecast To 2021

marketresearchglobe.com
Posted on: 26 Oct 16

Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Scope of the Report:
This report focuses on the Insulin Glargine in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

To Request Sample Copy of This Report: http://www.marketresearchglobe.com/request-sample/63439

Market Segment by Manufacturers, this report covers
Sanofi-Aventis
Ganlee
Biocon

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle East and Africa

Market Segment by Type, covers
Single Dose Vial
Pre-filled Syringe

Market Segment by Applications, can be divided into
Treat type 1 diabetes
Treat type 2 diabetes

Browse Complete Report http://www.marketresearchglobe.com/report/global-insulin-glargine-market-by-manufacturers-regions-type-and-application-forecast-to-2021

There are 13 Chapters to deeply display the global Insulin Glargine market.

Chapter 1, to describe Insulin Glargine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Insulin Glargine, with sales, revenue, and price of Insulin Glargine, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin Glargine, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Insulin Glargine market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Insulin Glargine sales channel, distributors, traders, dealers, appendix and data source.

About Us:

Market Research Globe is a proficient consulting company offering services associated to global market research. With assistance from ingenious database made by experts, it provides its customers a vast variety of customized marketing and business research solutions to choose from.

Contact us:

+91-8237031048

sales@marketresearchglobe.com

Editor's Details

sayali

Last updated on: 26/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.